GT Biopharma, Inc. announced that it has entered into agreements to exercise existing warrants for a total of 302,069 shares of its common stock at an exercise price of $4.35, which were issued in May ...
This aviation services leader reported a notable insider sale as shares continued to reflect strong performance over the past ...
PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company developing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and ...
TipRanks on MSN
Shareholders approve full exercise of outstanding warrants
The latest update is out from Creative Medical Technology Holdings ( ($CELZ) ). On December 26, 2025, Creative Medical Technology Holdings held a ...
Focused on rare liver disease therapies, this biopharma company reported a significant insider sale amid strong one-year stock gains.
TAMPA, Fla.--(BUSINESS WIRE)--American Integrity Insurance Group, Inc. (“American Integrity”) announced today that in connection with the previously announced initial public offering of 6,875,000 ...
PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / January 7, 2026 / Datavault AI Inc. (NASDAQ:DVLT) ("Datavault AI" or the ...
This clinical-stage biotech focused on precision medicines reported significant insider selling, according to recent SEC filings.
MOUNTAIN VIEW, Calif., Feb. 18, 2025 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE) today announced the completion of its previously announced underwritten public offering of 7,475,000 shares of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback